A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

This publication has 23 references indexed in Scilit:

• Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
  Vaccine, 2013
• Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
  BMC Infectious Diseases, 2013
• Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
  BMC Medicine, 2013
• Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
  BMC Infectious Diseases, 2013
• The Burden of Influenza B: A Structured Literature Review
  American Journal of Public Health, 2013
• The rationale for quadrivalent influenza vaccines
  Human Vaccines & Immunotherapeutics, 2012
• Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010
  Influenza and Other Respiratory Viruses, 2011
• Establishing the health and economic impact of influenza vaccination within the European Union 25 countries
  Vaccine, 2006
• Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
  Virology, 1990
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
  Epidemiology and Infection, 1972